clopidogrel [Bioanalytics]

posted by ioanam – Romania, 2010-08-10 20:34 (5781 d 05:39 ago) – Posting: # 5767
Views: 9,502

Dear Ohlbe
we have results from 63 subjects; the dose administered was 150 mg.

Thank you for the EPARs. I already compared our results with those reported there.
But I have other reports from other studies using the same dose (150 mg) and the results were lower than ours (in general around 2 - 3 ng/ml).

In this study, the between - subject variability is around 50% (?).

Even clopidogrel is a HVD, can I have such differences in the same subjects, eq:
- almost 6 ng/ml (for one formulation) compared to 15 ng/ml (the other formulation)
- almost 6 ng/ml compared to almost 19 ng/ml
or
- almost 3 ng/ml compared to almost 18 ng/ml?

These differences seems to be to high (for me). Perhaps I am wrong. I don't know.

Regards,
ioanam

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
228 visitors (0 registered, 228 guests [including 49 identified bots]).
Forum time: 02:14 CEST (Europe/Vienna)

The epistemological value of probability theory is based on the fact
that chance phenomena, considered collectively and on a grand scale,
create non-random regularity.    Andrey Kolmogorov

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5